Login to Your Account

Immunex Starts Second Phase III Study Of Enbrel For Psoriasis

By Brady Huggett

Monday, July 8, 2002
Immunex Corp. said at the 20th annual World Congress of Dermatology Meeting in Paris that it began a second Phase III trial of Enbrel in psoriasis as the company seeks its fifth approval for the drug. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription